21 CFR 358.301 - Scope.
prev | next
(a) An over-the-counter ingrown toenail relief drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each condition in this subpart and each general condition established in § 330.1 of this chapter.
Title 21 published on 2014-04-01
no entries appear in the Federal Register after this date.